AMAG Pharma Q3 Earnings Up Y/Y, Revenues Beat

AMAG Pharmaceuticals, Inc. reported adjusted earnings of $1.61 per share in the third quarter of 2016, up approximately 77% from the year-ago figure.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.